Relay Therapeutics, Inc. (RLAY) Tops Q4 EPS by 12c
Tweet
Share
E-mailGet Alerts RLAY Hot Sheet
Join SI Premium – FREE
Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q4 EPS of ($0.45), $0.12 better than the analyst estimate of ($0.57).
For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Guggenheim Reiterates Buy Rating on Relay Therapeutics (RLAY)
- Hamilton Insurance Group, Ltd. (HG) Reports Q2 EPS of $1.56
- El Pollo Loco (LOCO) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
